732 related articles for article (PubMed ID: 32730985)
1. Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.
García de Frutos A; González-Tartière P; Coll Bonet R; Ubierna Garcés MT; Del Arco Churruca A; Rivas García A; Matamalas Adrover A; Saló Bru G; Velazquez JJ; Vila-Canet G; García-Lopez J; Vives J; Codinach M; Rodriguez L; Bagó Granell J; Càceres Palou E
Spine J; 2020 Dec; 20(12):1899-1910. PubMed ID: 32730985
[TBL] [Abstract][Full Text] [Related]
2. Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).
vonderHoeh NH; Voelker A; Heyde CE
Eur Spine J; 2017 Nov; 26(11):2835-2842. PubMed ID: 28547573
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
4. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
Blanco JF; Villarón EM; Pescador D; da Casa C; Gómez V; Redondo AM; López-Villar O; López-Parra M; Muntión S; Sánchez-Guijo F
Stem Cell Res Ther; 2019 Feb; 10(1):63. PubMed ID: 30795797
[TBL] [Abstract][Full Text] [Related]
5. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
6. The effect of iliac crest autograft on the outcome of fusion in the setting of degenerative spondylolisthesis: a subgroup analysis of the Spine Patient Outcomes Research Trial (SPORT).
Radcliff K; Hwang R; Hilibrand A; Smith HE; Gruskay J; Lurie JD; Zhao W; Albert T; Weinstein J
J Bone Joint Surg Am; 2012 Sep; 94(18):1685-92. PubMed ID: 22878599
[TBL] [Abstract][Full Text] [Related]
7. [Adjacent segment degeneration after lumbosacral fusion in spondylolisthesis: a retrospective radiological and clinical analysis].
Zencica P; Chaloupka R; Hladíková J; Krbec M
Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):124-30. PubMed ID: 20447355
[TBL] [Abstract][Full Text] [Related]
8. Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft.
Chaverri D; Gallardo-Villares S; Pinto JA; Rodríguez L; Codinach M; García-López J; Querol S; Coll R; Vives J; Granell-Escobar F
Injury; 2024 Jul; 55(7):111596. PubMed ID: 38797000
[TBL] [Abstract][Full Text] [Related]
9. Radiological adjacent-segment degeneration in L4-5 spondylolisthesis: comparison between dynamic stabilization and minimally invasive transforaminal lumbar interbody fusion.
Kuo CH; Huang WC; Wu JC; Tu TH; Fay LY; Wu CL; Cheng H
J Neurosurg Spine; 2018 Sep; 29(3):250-258. PubMed ID: 29856306
[TBL] [Abstract][Full Text] [Related]
10. Bilateral implantation of low-profile interbody fusion cages: subsidence, lordosis, and fusion analysis.
Schiffman M; Brau SA; Henderson R; Gimmestad G
Spine J; 2003; 3(5):377-87. PubMed ID: 14588950
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized, double-blinded clinical trial comparing PEEK and allograft spacers in patients undergoing transforaminal lumbar interbody fusion surgeries.
Villavicencio AT; Nelson EL; Rajpal S; Beasley K; Burneikiene S
Spine J; 2022 Jan; 22(1):84-94. PubMed ID: 34116214
[TBL] [Abstract][Full Text] [Related]
12. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.
Burkus JK; Transfeldt EE; Kitchel SH; Watkins RG; Balderston RA
Spine (Phila Pa 1976); 2002 Nov; 27(21):2396-408. PubMed ID: 12438990
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion.
Jenis LG; Banco RJ; Kwon B
Spine J; 2006; 6(1):14-20. PubMed ID: 16413442
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiographic outcomes of concentrated bone marrow aspirate with allograft and demineralized bone matrix for posterolateral and interbody lumbar fusion in elderly patients.
Ajiboye RM; Hamamoto JT; Eckardt MA; Wang JC
Eur Spine J; 2015 Nov; 24(11):2567-72. PubMed ID: 26169879
[TBL] [Abstract][Full Text] [Related]
15. Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(6):1-57. PubMed ID: 23074475
[TBL] [Abstract][Full Text] [Related]
16. Transforaminal Lumbar Interbody Fusion With Viable Allograft: 75 Consecutive Cases at 12-Month Follow-up.
Tally WC; Temple HT; Subhawong TY; Ganey T
Int J Spine Surg; 2018 Jan; 12(1):76-84. PubMed ID: 30280087
[TBL] [Abstract][Full Text] [Related]
17. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment.
Sasso RC; LeHuec JC; Shaffrey C;
J Spinal Disord Tech; 2005 Feb; 18 Suppl():S77-81. PubMed ID: 15699810
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.
Choi JY; Park HJ; Park SM; Kang CN; Song KS
J Orthop Surg Res; 2022 Aug; 17(1):397. PubMed ID: 36045371
[TBL] [Abstract][Full Text] [Related]
19. Combining Expandable Interbody Cage Technology With a Minimally Invasive Technique to Harvest Iliac Crest Autograft Bone to Optimize Fusion Outcomes in Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery.
Virk S; Vaishnav AS; Sheha E; Urakawa H; Sato K; Othman Y; Chaudhary C; Lee R; Cong GT; Chaudhary S; Qureshi SA
Clin Spine Surg; 2021 Nov; 34(9):E522-E530. PubMed ID: 34224423
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic mesenchymal precursor cells (MPCs) combined with an osteoconductive scaffold to promote lumbar interbody spine fusion in an ovine model.
Wheeler DL; Fredericks DC; Dryer RF; Bae HW
Spine J; 2016 Mar; 16(3):389-99. PubMed ID: 26291397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
